Macular Pigment and Visual Performance in Glaucoma Patients

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 21, 2019

Primary Completion Date

November 9, 2021

Study Completion Date

November 9, 2021

Conditions
Glaucoma
Interventions
DRUG

Lutein, zeaxanthin and mesozeaxanthin

The intervention will involve supplementation with the macular carotenoids (1 pill daily with a meal containing lutein, zeaxanthin, mesozeaxanthin) for six months, to determine the effects on visual performance in glaucoma patients.

OTHER

Placebo

This intervention involves an inert pill (1 pill daily with a meal) that contains only sunflower oil, for six months.

Trial Locations (1)

27710

Duke University Eye Center, Durham

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Heidelberg Engineering GmbH

INDUSTRY

collaborator

MacuHealth

INDUSTRY

collaborator

Industrial Orgánica S.A. de C.V.

INDUSTRY

lead

Felipe Medeiros, MD

OTHER

NCT03959592 - Macular Pigment and Visual Performance in Glaucoma Patients | Biotech Hunter | Biotech Hunter